{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T19:00:20Z","timestamp":1775588420994,"version":"3.50.1"},"reference-count":63,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"DOI":"10.1210\/en.2016-1871","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T18:34:00Z","timestamp":1501785240000},"page":"3354-3368","source":"Crossref","is-referenced-by-count":7,"title":["Skeletal and Uterotrophic Effects of Endoxifen in Female Rats"],"prefix":"10.1210","volume":"158","author":[{"given":"Anne","family":"Gingery","sequence":"first","affiliation":[{"name":"Division of Orthopedic Research, Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota 55905"},{"name":"Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urszula T","family":"Iwaniec","sequence":"additional","affiliation":[{"name":"Skeletal Biology Laboratory, School of Biological and Population Health Sciences, Oregon State University, Corvallis, Oregon 97331"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malayannan","family":"Subramaniam","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell T","family":"Turner","sequence":"additional","affiliation":[{"name":"Skeletal Biology Laboratory, School of Biological and Population Health Sciences, Oregon State University, Corvallis, Oregon 97331"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin S","family":"Pitel","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee M","family":"McGovern","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel M","family":"Reid","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota 55905"},{"name":"Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J","family":"Marler","sequence":"additional","affiliation":[{"name":"Department of Comparative Medicine, Mayo Clinic, Scottsdale, Arizona 85259"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James N","family":"Ingle","sequence":"additional","affiliation":[{"name":"Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P","family":"Goetz","sequence":"additional","affiliation":[{"name":"Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R","family":"Hawse","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2017,8,3]]},"reference":[{"issue":"3","key":"2019041122284828200_B1","first-page":"1521","article-title":"trans-4-Hydroxytamoxifen concentration and metabolism after local percutaneous administration to human breast","volume":"46","author":"Mauvais-Javis","year":"1986","journal-title":"Cancer Res"},{"issue":"2","key":"2019041122284828200_B2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/B:BREA.0000025406.31193.e8","article-title":"Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen","volume":"85","author":"Johnson","year":"2004","journal-title":"Breast Cancer Res Treat"},{"issue":"16","key":"2019041122284828200_B3","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1200\/JCO.2009.23.8931","article-title":"Coprescription of tamoxifen and medications that inhibit CYP2D6","volume":"28","author":"Sideras","year":"2010","journal-title":"J Clin Oncol"},{"issue":"23","key":"2019041122284828200_B4","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/jnci\/djg108","article-title":"Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine","volume":"95","author":"Stearns","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"2019041122284828200_B5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/clpt.2011.27","article-title":"Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma","volume":"89","author":"M\u00fcrdter","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"2019041122284828200_B6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.carres.2013.02.003","article-title":"CuAAC-mediated diversification of aminoglycoside-arginine conjugate mimics by non-reducing di- and trisaccharides","volume":"371","author":"Westermann","year":"2013","journal-title":"Carbohydr Res"},{"issue":"5","key":"2019041122284828200_B7","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1158\/0008-5472.CAN-08-3933","article-title":"The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cells","volume":"69","author":"Wu","year":"2009","journal-title":"Cancer Res"},{"issue":"2","key":"2019041122284828200_B8","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/bcr2844","article-title":"Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen","volume":"13","author":"Wu","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"5","key":"2019041122284828200_B9","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/clpt.2011.32","article-title":"Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomes","volume":"89","author":"Madlensky","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"2019041122284828200_B10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1200\/JCO.2012.44.6625","article-title":"Tamoxifen use in postmenopausal breast cancer: CYP2D6 matters","volume":"31","author":"Brauch","year":"2013","journal-title":"J Clin Oncol"},{"issue":"3","key":"2019041122284828200_B11","first-page":"253","article-title":"Tamoxifen, raloxifene, and the prevention of breast cancer","volume":"20","author":"Jordan","year":"1999","journal-title":"Endocr Rev"},{"issue":"7","key":"2019041122284828200_B12","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJMra022219","article-title":"Selective estrogen-receptor modulators\u2014mechanisms of action and application to clinical practice","volume":"348","author":"Riggs","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"2019041122284828200_B13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1034\/j.1600-0463.2001.090503.x","article-title":"Tissue-specific expression pattern of estrogen receptors (ER): quantification of ER\u03b1 and ER\u03b2 mRNA with real-time RT-PCR","volume":"109","author":"Pfaffl","year":"2001","journal-title":"APMIS"},{"issue":"3","key":"2019041122284828200_B14","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1091\/mbc.e03-06-0360","article-title":"Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors \u03b1 and \u03b2","volume":"15","author":"Tee","year":"2004","journal-title":"Mol Biol Cell"},{"issue":"3","key":"2019041122284828200_B15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1210\/endo.138.3.4979","article-title":"Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors \u03b1 and \u03b2","volume":"138","author":"Kuiper","year":"1997","journal-title":"Endocrinology"},{"issue":"9","key":"2019041122284828200_B16","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1074\/jbc.M208501200","article-title":"Differential SERM effects on corepressor binding dictate ER\u03b1 activity in vivo","volume":"278","author":"Webb","year":"2003","journal-title":"J Biol Chem"},{"issue":"3","key":"2019041122284828200_B17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1096-7192(02)00043-4","article-title":"Effects of selective estrogen receptor modulators (SERMs) on coactivator nuclear receptor (NR) box binding to estrogen receptors","volume":"76","author":"Bramlett","year":"2002","journal-title":"Mol Genet Metab"},{"issue":"3","key":"2019041122284828200_B18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/2053369115599090","article-title":"Selective estrogen receptor modulators and the combination therapy conjugated estrogens\/bazedoxifene: a review of effects on the breast","volume":"21","author":"Pickar","year":"2015","journal-title":"Post Reprod Health"},{"issue":"1","key":"2019041122284828200_B19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.maturitas.2014.10.010","article-title":"Selective estrogen receptor modulators (SERMs): a review of clinical data","volume":"80","author":"Mirkin","year":"2015","journal-title":"Maturitas"},{"issue":"1","key":"2019041122284828200_B20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/ciia.2007.2.1.55","article-title":"The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis","volume":"2","author":"Migliaccio","year":"2007","journal-title":"Clin Interv Aging"},{"issue":"3","key":"2019041122284828200_B21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/humupd\/6.3.212","article-title":"A pharmacological review of selective oestrogen receptor modulators","volume":"6","author":"Goldstein","year":"2000","journal-title":"Hum Reprod Update"},{"issue":"2","key":"2019041122284828200_B22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrd3299","article-title":"Emerging therapeutic opportunities for skeletal restoration","volume":"10","author":"Kawai","year":"2011","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2019041122284828200_B23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01807038","article-title":"Ovarian status influences the skeletal effects of tamoxifen in adult rats","volume":"41","author":"Sibonga","year":"1996","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2019041122284828200_B24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.1996.14.1.78","article-title":"Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women","volume":"14","author":"Powles","year":"1996","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019041122284828200_B25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10549-010-1072-z","article-title":"Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells","volume":"128","author":"Berstein","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"2019041122284828200_B26","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1200\/JCO.2007.11.0726","article-title":"Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230","volume":"26","author":"Eastell","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"2019041122284828200_B27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.maturitas.2011.11.018","article-title":"An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis","volume":"71","author":"Komm","year":"2012","journal-title":"Maturitas"},{"key":"2019041122284828200_B28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jsbmb.2014.03.003","article-title":"An overview of current and emerging SERMs","volume":"143","author":"Komm","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"22","key":"2019041122284828200_B29","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2007.12.3430","article-title":"Bone density in breast cancer: when to intervene?","volume":"25","author":"Gralow","year":"2007","journal-title":"J Clin Oncol"},{"issue":"22","key":"2019041122284828200_B30","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/jnci\/85.22.1850","article-title":"Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer","volume":"85","author":"Fornander","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"2019041122284828200_B31","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/jnci\/91.19.1654","article-title":"Tamoxifen therapy for breast cancer and endometrial cancer risk","volume":"91","author":"Bernstein","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2019041122284828200_B32","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ctrv.2011.06.009","article-title":"Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review","volume":"38","author":"Iqbal","year":"2012","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"2019041122284828200_B33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.imlet.2004.10.015","article-title":"Toll-like receptor 9 signaling can sensitize fibroblasts for apoptosis","volume":"97","author":"Fischer","year":"2005","journal-title":"Immunol Lett"},{"issue":"9793","key":"2019041122284828200_B34","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(11)61128-8","article-title":"With maturity comes confidence: EBCTCG tamoxifen update","volume":"378","author":"Chia","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"2019041122284828200_B35","doi-asserted-by":"crossref","first-page":"e54613","DOI":"10.1371\/journal.pone.0054613","article-title":"Endoxifen\u2019s molecular mechanisms of action are concentration dependent and different than that of other anti-estrogens","volume":"8","author":"Hawse","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"2019041122284828200_B36","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/bcr2844","article-title":"Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen","volume":"13","author":"Wu","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"2","key":"2019041122284828200_B37","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jcb.23443","article-title":"Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody","volume":"113","author":"Wu","year":"2012","journal-title":"J Cell Biochem"},{"issue":"2","key":"2019041122284828200_B38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/rep.0.1220215","article-title":"Intraovarian actions of oestrogen","volume":"122","author":"Rosenfeld","year":"2001","journal-title":"Reproduction"},{"issue":"5","key":"2019041122284828200_B39","doi-asserted-by":"crossref","first-page":"e98219","DOI":"10.1371\/journal.pone.0098219","article-title":"The effects of a novel hormonal breast cancer therapy, endoxifen, on the mouse skeleton","volume":"9","author":"Gingery","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"2019041122284828200_B40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2106\/00004623-195032010-00014","article-title":"Endosteal-bone formation in estrogen-treated mice","volume":"32A","author":"Urist","year":"1950","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"2019041122284828200_B41","first-page":"424","article-title":"The laboratory rat as an animal model for osteoporosis research","volume":"58","author":"Lelovas","year":"2008","journal-title":"Comp Med"},{"issue":"8","key":"2019041122284828200_B42","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1073\/pnas.94.8.4199","article-title":"Estrogen regulates the rate of bone turnover but bone balance in ovariectomized rats is modulated by prevailing mechanical strain","volume":"94","author":"Westerlind","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2019041122284828200_B43","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1359\/jbmr.080319","article-title":"Tamoxifen impairs both longitudinal and cortical bone growth in young male rats","volume":"23","author":"Karimian","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2019041122284828200_B44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jbmr.5650020206","article-title":"The effects of ovariectomy and 17\u03b2-estradiol on cortical bone histomorphometry in growing rats","volume":"2","author":"Turner","year":"1987","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2019041122284828200_B45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jbmr.5650020513","article-title":"Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats","volume":"2","author":"Turner","year":"1987","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2019041122284828200_B46","first-page":"883","article-title":"Mechanism of action of estrogen on intramembranous bone formation: regulation of osteoblast differentiation and activity","volume":"131","author":"Turner","year":"1992","journal-title":"Endocrinology"},{"issue":"3","key":"2019041122284828200_B47","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1210\/endo-127-3-1346","article-title":"Estrogen inhibition of periosteal bone formation in rat long bones: down-regulation of gene expression for bone matrix proteins","volume":"127","author":"Turner","year":"1990","journal-title":"Endocrinology"},{"issue":"3","key":"2019041122284828200_B48","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/endo-129-3-1568","article-title":"Dose-dependent effects of tamoxifen on long bones in growing rats: influence of ovarian status","volume":"129","author":"Moon","year":"1991","journal-title":"Endocrinology"},{"issue":"4","key":"2019041122284828200_B49","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1200\/JCO.2005.02.3515","article-title":"Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status","volume":"24","author":"Vehmanen","year":"2006","journal-title":"J Clin Oncol"},{"issue":"18","key":"2019041122284828200_B50","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1200\/JCO.2004.08.148","article-title":"Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy","volume":"22","author":"Sverrisd\u00f3ttir","year":"2004","journal-title":"J Clin Oncol"},{"issue":"4","key":"2019041122284828200_B51","first-page":"207","article-title":"Effects of ovariectomy and tamoxifen on rat bone tissue: histomorphometric and histopathologic study","volume":"28","author":"Aktug","year":"2006","journal-title":"Anal Quant Cytol Histol"},{"issue":"8","key":"2019041122284828200_B52","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1177\/0192623314525688","article-title":"Comparative uterotrophic effects of endoxifen and tamoxifen in ovariectomized Sprague-Dawley rats","volume":"42","author":"Schweikart","year":"2014","journal-title":"Toxicol Pathol"},{"issue":"2","key":"2019041122284828200_B53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/toxsci\/48.2.197","article-title":"Compartmentalized uterotrophic effects of tamoxifen, toremifene, and estradiol in the ovariectomized Wistar (Han) rat","volume":"48","author":"Carthew","year":"1999","journal-title":"Toxicol Sci"},{"key":"2019041122284828200_B54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1477-7827-1-40","article-title":"Effects of SERM (selective estrogen receptor modulator) treatment on growth and proliferation in the rat uterus","volume":"1","author":"Stygar","year":"2003","journal-title":"Reprod Biol Endocrinol"},{"key":"2019041122284828200_B55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1755-8794-2-19","article-title":"Tamoxifen-elicited uterotrophy: cross-species and cross-ligand analysis of the gene expression program","volume":"2","author":"Kwekel","year":"2009","journal-title":"BMC Med Genomics"},{"issue":"3","key":"2019041122284828200_B56","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1525-1373.2000.22341.x","article-title":"Effects of oral administration of tamoxifen, toremifene, dehydroepiandrosterone, and vorozole on uterine histomorphology in the rat","volume":"223","author":"Nephew","year":"2000","journal-title":"Proc Soc Exp Biol Med"},{"key":"2019041122284828200_B57","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1186\/1471-2407-14-749","article-title":"ER\u03b21: characterization, prognosis, and evaluation of treatment strategies in ER\u03b1-positive and -negative breast cancer","volume":"14","author":"Reese","year":"2014","journal-title":"BMC Cancer"},{"issue":"48","key":"2019041122284828200_B58","doi-asserted-by":"crossref","first-page":"18350","DOI":"10.1073\/pnas.0608861103","article-title":"Role of estrogen receptor \u03b2 in uterine stroma and epithelium: Insights from estrogen receptor \u03b2\u2212\/\u2212 mice","volume":"103","author":"Wada-Hiraike","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2019041122284828200_B59","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1210\/en.2015-1012","article-title":"Neonatal estrogen receptor \u03b2 is important in the permanent inhibition of epithelial cell proliferation in the mouse uterus","volume":"156","author":"Nakajima","year":"2015","journal-title":"Endocrinology"},{"issue":"1-2","key":"2019041122284828200_B60","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0303-7207(00)00248-3","article-title":"Effect of tamoxifen treatment on the endometrial expression of human insulin-like growth factors and their receptor mRNAs","volume":"165","author":"Roy","year":"2000","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"2019041122284828200_B61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1677\/joe.0.1660087","article-title":"Expression of proliferating cell nuclear antigen in luminal epithelium during the growth and regression of rat uterus","volume":"166","author":"Lai","year":"2000","journal-title":"J Endocrinol"},{"issue":"3","key":"2019041122284828200_B62","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1677\/jme.0.0280213","article-title":"Differential expression of secreted frizzled-related protein 4 in decidual cells during pregnancy","volume":"28","author":"Fujita","year":"2002","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"2019041122284828200_B63","doi-asserted-by":"crossref","first-page":"186.e1","DOI":"10.1016\/j.ajog.2008.08.064","article-title":"Enhanced estrogen-induced proliferation in obese rat endometrium","volume":"200","author":"Zhang","year":"2009","journal-title":"Am J Obstet Gynecol"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/158\/10\/3354\/20424595\/en.2016-1871.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T17:22:43Z","timestamp":1555089763000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/158\/10\/3354\/4060084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,3]]},"references-count":63,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,8,3]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2016-1871","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10,1]]},"published":{"date-parts":[[2017,8,3]]}}}